Result: Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer

*Title*:

Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer / Mike Wenzel [und weitere]

*Author/editor-in-chief*:

Wenzel, Mike (Verfasser)

*Published in*:

World journal of urology. - Berlin ; Heidelberg : Springer, 28.12.2024. - Seite 1-7. - 10.1007/s00345-024-05388-1. - ISSN 1433-8726. - Jahrgang 43, Artikel 51

*Publication*:

Berlin ; Heidelberg : Springer, [28.12.2024]

*Distribution*:

Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg

*Physical description scale*:

1 Online-Ressource (7 Seiten)

*Format*:

*eBook*

*Language*:

*eng*

*DOI*:

10.1007/s00345-024-05388-1

*oa_rights*:

Open Access
CC BY 4.0

*Result*: Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer

*Additional information*

*Additional functions*

Result: Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer

Additional information

Additional functions